ClinicalTrials.govpublic full text
A Study Comparing Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on a Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response to csDMARDs Alone
rheumatoid arthritis, musculoskeletal disease, arthritis, joint disease, anti-inflammatory agents, antirheumatic agents, upadacitinib, abt-494, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 878822
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.